Our aim is to selectively express the DAT protein in dopaminergic neurons of the SN to anatomically restrict AAV’s action on A9 DA neurons projecting to DS, therefore acting on the primary DA area involved in motor control, whose dysfunction has been thoroughly characterized in our mouse model17, 18, 24, 26. Here, SLC6A3 is linked to Dravet syndrome.